Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadel...
Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow-up of the phase 3 randomised ENESTnd trial
About this item
Full title
Author / Creator
Kantarjian, Hagop M, Prof , Hochhaus, Andreas, Prof , Saglio, Giuseppe, Prof , De Souza, Carmino, Prof , Flinn, Ian W, MD , Stenke, Leif, MD , Goh, Yeow-Tee, MD , Rosti, Gianantonio, Prof , Nakamae, Hirohisa, MD , Gallagher, Neil J, MD , Hoenekopp, Albert, MD , Blakesley, Rick E, PhD , Larson, Richard A, Prof and Hughes, Timothy P, Prof
Publisher
England: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Summary Background Nilotinib has shown greater efficacy than imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukaemia (CML) in chronic phase after a minimum follow-up of 12 months. We present data from the Evaluating Nilotinib Efficacy and Safety in clinical Trials–newly diagnosed patients (ENESTnd) study...
Alternative Titles
Full title
Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow-up of the phase 3 randomised ENESTnd trial
Authors, Artists and Contributors
Author / Creator
Hochhaus, Andreas, Prof
Saglio, Giuseppe, Prof
De Souza, Carmino, Prof
Flinn, Ian W, MD
Stenke, Leif, MD
Goh, Yeow-Tee, MD
Rosti, Gianantonio, Prof
Nakamae, Hirohisa, MD
Gallagher, Neil J, MD
Hoenekopp, Albert, MD
Blakesley, Rick E, PhD
Larson, Richard A, Prof
Hughes, Timothy P, Prof
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_swepub_primary_oai_swepub_ki_se_542343
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_swepub_ki_se_542343
Other Identifiers
ISSN
1470-2045,1474-5488
E-ISSN
1474-5488
DOI
10.1016/S1470-2045(11)70201-7
